Skip to content
Joyful Ventures logo
Venture CapitalExempt Reporting Adviser · CRD 322659Private Fund Adviser

Updated:

Joyful Ventures

Joyful Ventures, co-founded by Jennifer Stojkovic, invests early-stage capital into alternative-protein startups using fermentation and plant biology.

Overview

Joyful Ventures is a venture capital fund that invests in alternative protein sources.

General information

Firm type

Venture Capital

Year founded

2023

Location

Region

North America

Country

United States

City

West Hollywood

Corporate office

West Hollywood, CA, United States

Sector focus

Plant-basedFermentationCultivated Meats

Frequently asked questions

How does Joyful Ventures source its proprietary deal flow?

Joyful's sourcing advantage derives from deep embedding in the alternative-protein ecosystem, including university food-science labs, industry conferences, and mission-aligned accelerator programs such as Big Idea Ventures. The firm's advocacy-network position — particularly Stojkovic's convening platform — provides early visibility into pre-institutional start-ups emerging from academic and non-profit food-tech initiatives. The firm does not operate a public accelerator or incubator itself.

Which sectors does Joyful Ventures explicitly avoid?

Joyful does not invest in conventional animal agriculture, including technology that improves the efficiency of factory farming. The firm also avoids plant-based meat analogues that rely on commodity supply chains without proprietary IP; the thesis requires defensible technology moats in bioprocessing, cell biology, or food-material science. Climate-tech sectors outside food — energy, mobility, carbon capture — are explicitly not in scope.

How is Joyful Ventures' performance measured against non-financial objectives?

The firm publicly frames animal welfare and climate impact as core mandate objectives alongside financial returns, though it has not disclosed a formal impact-measurement framework. The investment thesis itself — replacing animal-sourced proteins with fermentation-derived and cultivated alternatives — functions as the impact mechanism, rather than a parallel program of grants or concessional capital. LP reporting standards on non-financial outcomes have not been publicly detailed.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Venture Capital profiles